2023 SABCS Presentation: Liquid biopsy determination of HER2 status in breast cancer: results from a novel epigenomic platform
2023 SABCS Presentation: Liquid biopsy determination of HER2 status in breast cancer: results from a novel epigenomic platform
2023 SABCS Poster: Liquid biopsy determination of HER2 status in breast cancer: results from a novel epigenomic platform
2023 SABCS Poster: Liquid biopsy determination of HER2 status in breast cancer: results from a novel epigenomic platform
2023 ESMO Presentation: Clinical subtyping of cancer from plasma based on comprehensive epigenomic profiling
2023 ESMO Presentation: Clinical subtyping of cancer from plasma based on comprehensive epigenomic profiling